Lombard Medical Inc. (EVARF)
OTC PINK OTC PINK Primary Summary
EVARF Chart
Lombard Medical Inc. Dividends
Lombard Medical Inc. Earnings
| 9 May 2024 Date | | - Cons. EPS | - EPS |
| 28 Feb 2024 Date | | - Cons. EPS | - EPS |
| 27 Nov 2023 Date | | - Cons. EPS | - EPS |
| 21 Nov 2023 Date | | - Cons. EPS | - EPS |
| 13 Nov 2023 Date | | - Cons. EPS | - EPS |
| 9 May 2024 Date | | - Cons. EPS | - EPS |
| 28 Feb 2024 Date | | - Cons. EPS | - EPS |
| 27 Nov 2023 Date | | - Cons. EPS | - EPS |
| 21 Nov 2023 Date | | - Cons. EPS | - EPS |
| 13 Nov 2023 Date | | - Cons. EPS | - EPS |
Lombard Medical Inc. (EVARF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Lombard Medical Inc. ever had a stock split?
Lombard Medical Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Kurt B. Lemvigh CEO | OTC PINK Exchange | KYG555981094 ISIN |
| GB Country | 113 Employees | - Last Dividend | - Last Split | 13 Dec 2005 IPO Date |
Overview
Lombard Medical, Inc. is a pioneering medical technology company dedicated to developing, manufacturing, and distributing endovascular stent-grafts used in the repair of aortic aneurysms. The company operates globally, with a significant presence in the United States, the United Kingdom, Germany, Japan, and other international markets. Since its inception in 2000, Lombard Medical has focused on addressing the complex challenges associated with aortic aneurysm repairs, primarily through its flagship product, Aorfix. The company's commitment to innovation is evident in its comprehensive product line designed for various aneurysm anatomies and complexities. Headquartered in Didcot, the United Kingdom, Lombard Medical, Inc. leverages a combination of direct sales force and distributors to make its cutting-edge solutions accessible to state-or-government-owned hospitals worldwide.
Products and Services
- Aorfix:
- Altura:
- Aorflex Delivery System:
- IntelliFlex LP Delivery System:
A pivotal endovascular stent-graft designed for the treatment of abdominal aortic aneurysms (AAAs), particularly those with angulations at the neck of the aneurysm up to 90 degrees. Aorfix's unique flexibility offers a versatile and effective solution for a wide range of AAA geometries, contributing to improved patient outcomes.
An innovative endovascular stent graft system specifically developed for the treatment of standard AAA anatomies. The Altura system's design simplifies the procedure, allowing for a minimally invasive approach that significantly reduces the recovery time and risks associated with traditional open surgery.
This delivery system is engineered to facilitate the precise placement of Aorfix within the abdominal aorta. The Aorflex technology enhances the surgeon's ability to navigate challenging anatomical structures, ensuring optimal alignment and securement of the stent-graft.
A state-of-the-art delivery system that extends the capabilities of Aorfix deployment. The IntelliFlex LP Delivery System introduces enhanced precision and control during the stent-graft placement, reinforcing Lombard Medical's commitment to technological advancement and surgical excellence.
Contact Information
